CClinicalTrials.gg
Status unknownNCT05213741Updated Apr 20, 2023

Feasibility Trial of Magnetic-assisted Colonoscope Platform

An interventional study of Autonomous navigation of a magnetic colonoscope in Colonoscopy and Colorectal Cancer, sponsored by Taipei Medical University WanFang Hospital. Status unknown. Open to participants aged 20 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-04-20.

Sponsored by Taipei Medical University WanFang Hospital · Not applicable, Interventional, and Device feasibility

The sponsor has not verified this record recently (last verified Apr 2023), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
20 Years to 65 Years
Sex
All
01

Study summary

Colorectal cancer (CRC) screening program can reduce colon cancer-related mortality. Current CRC screening methods include stool occult blood and DNA testing, blood based tests and radiologic tests. Colonoscopy is considered the gold standard to detect colorectal neoplasms. Previous studies have estimated that cancer mortality to be 68% to 88% lower among persons who undergo screening colonoscopy than among those who do not. However, colonoscopy is an invasive examination, and 10% to 20% of patients fail to tolerate the procedure; therefore, greatly reduces the success rate of completion of colon examination.

External controllability of capsule endoscope by means of an applied magnetic field is a possible solution to the maneuvering problem. However, there is no effective system with straight forward clinical applicability till now. This is ascribable to a lack of reliable magnetic instrumentation suitable for such a purpose. We have reported that magnetic field navigator (MFN) can effectively control the locomotion of capsule endoscope. We have demonstrated the feasibility and safety of magnetic-assisted capsule endoscope for the examination of upper gastrointestinal tract. In this study, we develop a magnetic-assisted capsule colonoscope by combination of the integrated circuit complementary metal-oxide-semiconductor imaging sensor, light-emitting diode, and magnetic control technology. This magnetic-assisted capsule colonoscope operation system includes a MFN Platform, high-end hand-controlled joystick, combined circuit component, control interface and software. This magnetic-assisted capsule colonoscope operation system creates a friendly operating environment for the operators, and may establishe a novel screening system for the colon.

Read the detailed description
  1. Preparation before examination: All subjects must take bowel cleansing drugs as instructed before magnetically controlled colonoscopy After starting to drink laxatives, subjects should continue their daily activities .
  2. Magnetically Controlled Colonoscopy procedure:

    No anesthesia will be used during the magnetically controlled colonoscopy in this experiment.

    The subjects lie down on the magnetic control colonoscopy platform. After the magnetically controlled colonoscopy enters the rectum from the subject's anus, the external magnetron is used to assist and guide the pre-colonoscopy after the magnetically controlled colonoscopy enters the rectum from the subject's anus, and the external magnetron is used to assist and guide the colonoscopy go ahead. During the inspection process, the physician monitors the operation of the magnetically controlled colonoscope throughout the process, and the physician can adjust the movement of the colonoscope when necessary.

    Whole colorectal examination is defined as the colonoscope must be inserted into the ileocecal region, and the cecum must be photographed.

  3. Pain assessment during examination:

    During the colonoscopy, the researchers will conduct a questionnaire to the patients to assess the pain..

    The evaluation method is based on the Verbal Scale to evaluate the maximum discomfort, from 0 to 10 points; ; Among them, 0 points are painless, 10 points are the most severe.

    If the patient's pain assessment score is greater than 5 and the patient cannot tolerate colonoscopy, the examination will be terminated.

    If there are difficulties during the examination, and the magnetic-controlled colonoscopy cannot complete the examination within 1 hours, the examination shall be terminated.

  4. After the colonoscopy is completed, the researcher conducts an overall pain assessment to the subjects by means of a questionnaire. On the day after the colonoscopy, the researcher asked the subjects whether they would like to accept the next colonoscopy follow-up examination by means of a questionnaire.
  5. After the magnetic-controlled colonoscopy, the images and time recorded by the colonoscopy will be interpreted by computer-captured images, and the completion rate of the magnetic-controlled colonoscopy will be analyzed.
02

Conditions studied

  • Colonoscopy
  • Colorectal Cancer

Keywords

  • Colonoscopy
  • Magnetic-assisted
03

In context

Colorectal Neoplasms

5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's planned enrollment of 10 is below the median of 77 across 4,123 interventional studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

Taipei Medical University WanFang Hospital is the lead sponsor of 196 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Aged 20-65 health volunteers without any contraindication

Exclusion criteria

Exclusion Criteria:

  1. Person allergy to polyethylene glycol.
  2. Phenylkentouria
  3. Congestive heart failure (NYHA grade 3)
  4. Renal function impairment.
  5. Difficulty in swallowing, GI perforation, GI bleeding, toxic enterocolitis, toxic colitis, megacolon, diverticulitis, peritonitis
  6. Body weight less than 20kg
  7. Wrist more than 120cm
  8. Gastrointestinal tract obstruction
  9. Pregnant woman.
  10. Person with electrical medical implantation such as pacemaker, cochlear implant or other medical devices.
  11. Person implanted with metal medical device such as metal implantation, metallic stent, metallic denture, metallic valve, metallic joint, metallic joint or plate.
  12. Person with history of abdominal surgery.
  13. Person with cancer.
  14. Person with bleeding tendency
  15. Person with asthma
  16. History of cardiac infraction, pulmonary embolism, stroke in recent 6 months
  17. Heart failure with NYHA grades 4
05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Magnetic-assisted colonoscopy group

    Participants in this group will recieve magnetic-assisted colonoscopic examination

    Device: Autonomous navigation of a magnetic colonoscope

Interventions

  • DeviceAutonomous navigation of a magnetic colonoscope

    The proposed magnetic-assisted colonoscope system consists of an megnetic field nevigator, magnetic-assisted colonoscope, and image receiving decoder. All participants will receive the magnetic-assisted colonoscopic examination by using this proposed magnetic-assisted colonoscope system

06

What researchers measure

Primary outcomes

  1. Feasibility of magnetic-assisted colonoscope system

    The completion rate of colonoscopic examination by using the magnetic-assisted colonoscope system

    Time frame: The end of colonoscopic examination

  2. Safety of magnetic-assisted colonoscope system

    The complication rate of colonoscopic examination by using the magnetic-assisted

    Time frame: The end of colonoscopic examination

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Lien GS, Liu CW, Jiang JA, Chuang CL, Teng MT. Magnetic control system targeted for capsule endoscopic operations in the stomach--design, fabrication, and in vitro and ex vivo evaluations. IEEE Trans Biomed Eng. 2012 Jul;59(7):2068-79. doi: 10.1109/TBME.2012.2198061. Epub 2012 May 7. PubMed 22581127 ↗
  • Yang CS, Suk FM, Chen CN, Chuang CL, Jiang JA, Liu CW, Lien GS. Colonoscopy with magnetic control system to navigate the forepart of colonoscope shortens the cecal intubation time. Surg Endosc. 2014 Aug;28(8):2480-3. doi: 10.1007/s00464-014-3460-7. Epub 2014 Mar 20. PubMed 24648105 ↗
  • Huang HE, Yen SY, Chu CF, Suk FM, Lien GS, Liu CW. Autonomous navigation of a magnetic colonoscope using force sensing and a heuristic search algorithm. Sci Rep. 2021 Aug 13;11(1):16491. doi: 10.1038/s41598-021-95760-7. PubMed 34389760 ↗
  • Lien GS, Wu MS, Chen CN, Liu CW, Suk FM. Feasibility and safety of a novel magnetic-assisted capsule endoscope system in a preliminary examination for upper gastrointestinal tract. Surg Endosc. 2018 Apr;32(4):1937-1944. doi: 10.1007/s00464-017-5887-0. Epub 2017 Oct 25. PubMed 29071416 ↗
  • Yen SY, Huang HE, Lien GS, Liu CW, Chu CF, Huang WM, Suk FM. Automatic lumen detection and magnetic alignment control for magnetic-assisted capsule colonoscope system optimization. Sci Rep. 2021 Mar 19;11(1):6460. doi: 10.1038/s41598-021-86101-9. PubMed 33742067 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 20, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05213741
Lead sponsor
Taipei Medical University WanFang Hospital
Collaborators
Ministry of Health and Welfare, Taiwan
Responsible party
Fat-Moon Suk (Attending physician, Taipei Medical University WanFang Hospital) — Principal investigator
First posted
Jan 28, 2022
Start date
May 2024 (estimated)
Primary completion
Dec 2024 (estimated)
Completion
Dec 2024 (estimated)
Last update
Apr 20, 2023

Study contacts

FAT-MOON SUK, M.D.
Contact
sukfm@yahoo.com
+886229307930 ext. 1541
FAT-MOON SUK, M.D.
principal investigator · Taipei Medical University Wan Fang Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion